
Robert M. Kelly
Examiner (ID: 8, Phone: (571)272-0729 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1631, 1638, 1633, 1632 |
| Total Applications | 1411 |
| Issued Applications | 804 |
| Pending Applications | 145 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20178366
[patent_doc_number] => 20250262324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => Circular RNA Compositions
[patent_app_type] => utility
[patent_app_number] => 19/200761
[patent_app_country] => US
[patent_app_date] => 2025-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19200761
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/200761 | Circular RNA Compositions | May 6, 2025 | Pending |
Array
(
[id] => 20178366
[patent_doc_number] => 20250262324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => Circular RNA Compositions
[patent_app_type] => utility
[patent_app_number] => 19/200761
[patent_app_country] => US
[patent_app_date] => 2025-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19200761
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/200761 | Circular RNA Compositions | May 6, 2025 | Pending |
Array
(
[id] => 20099031
[patent_doc_number] => 20250228967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => AAV CAPSID VARIANTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/097114
[patent_app_country] => US
[patent_app_date] => 2025-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19097114
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/097114 | AAV capsid variants and uses thereof | Mar 31, 2025 | Issued |
Array
(
[id] => 20032053
[patent_doc_number] => 20250170275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 19/046845
[patent_app_country] => US
[patent_app_date] => 2025-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/046845 | METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA | Feb 5, 2025 | Pending |
Array
(
[id] => 20032053
[patent_doc_number] => 20250170275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 19/046845
[patent_app_country] => US
[patent_app_date] => 2025-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/046845 | METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA | Feb 5, 2025 | Pending |
Array
(
[id] => 20032053
[patent_doc_number] => 20250170275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 19/046845
[patent_app_country] => US
[patent_app_date] => 2025-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/046845 | METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA | Feb 5, 2025 | Pending |
| 63/834389 | SYNTHETIC CANCER-SPECIFIC PROMOTERS | Jan 21, 2025 | Pending |
Array
(
[id] => 19707893
[patent_doc_number] => 20250018035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => METHOD FOR EFFICIENTLY INFECTING HUMAN NATURAL KILLER CELLS AND OTHER IMMUNE CELLS WITH PSEUDOVIRUS
[patent_app_type] => utility
[patent_app_number] => 18/900968
[patent_app_country] => US
[patent_app_date] => 2024-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900968
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/900968 | Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus | Sep 29, 2024 | Issued |
Array
(
[id] => 19968484
[patent_doc_number] => 12337068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Lipid nanoparticle compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/886134
[patent_app_country] => US
[patent_app_date] => 2024-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 195
[patent_figures_cnt] => 228
[patent_no_of_words] => 58745
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/886134 | Lipid nanoparticle compositions and uses thereof | Sep 15, 2024 | Issued |
Array
(
[id] => 20212592
[patent_doc_number] => 12409226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Delivery and formulation of engineered nucleic acids
[patent_app_type] => utility
[patent_app_number] => 18/821057
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 39777
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821057 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 20115079
[patent_doc_number] => 12364763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Delivery and formulation of engineered nucleic acids
[patent_app_type] => utility
[patent_app_number] => 18/820652
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 39844
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/820652 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 19845315
[patent_doc_number] => 20250090666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/820609
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/820609 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 19799012
[patent_doc_number] => 20250064937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/821068
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821068
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821068 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 20212592
[patent_doc_number] => 12409226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Delivery and formulation of engineered nucleic acids
[patent_app_type] => utility
[patent_app_number] => 18/821057
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 39777
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821057 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 20212592
[patent_doc_number] => 12409226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Delivery and formulation of engineered nucleic acids
[patent_app_type] => utility
[patent_app_number] => 18/821057
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 39777
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821057 | Delivery and formulation of engineered nucleic acids | Aug 29, 2024 | Issued |
Array
(
[id] => 19903127
[patent_doc_number] => 12280111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Gene-regulating compositions and methods for improved immunotherapy
[patent_app_type] => utility
[patent_app_number] => 18/796740
[patent_app_country] => US
[patent_app_date] => 2024-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 34
[patent_no_of_words] => 78363
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18796740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/796740 | Gene-regulating compositions and methods for improved immunotherapy | Aug 6, 2024 | Issued |
Array
(
[id] => 19658816
[patent_doc_number] => 20240425881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/777787
[patent_app_country] => US
[patent_app_date] => 2024-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/777787 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Jul 18, 2024 | Issued |
Array
(
[id] => 19871472
[patent_doc_number] => 12264317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Compositions and methods for treating non-age-associated hearing impairment in a human subject
[patent_app_type] => utility
[patent_app_number] => 18/777187
[patent_app_country] => US
[patent_app_date] => 2024-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 90808
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777187
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/777187 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Jul 17, 2024 | Issued |
Array
(
[id] => 19722677
[patent_doc_number] => 20250025428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 18/765147
[patent_app_country] => US
[patent_app_date] => 2024-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765147 | COMPOSITIONS AND METHODS FOR DELIVERING MOLECULES | Jul 4, 2024 | Pending |
Array
(
[id] => 19570464
[patent_doc_number] => 20240374756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => AAV CAPSID VARIANTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/757141
[patent_app_country] => US
[patent_app_date] => 2024-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 139705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757141
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/757141 | AAV capsid variants and uses thereof | Jun 26, 2024 | Issued |